Showing 1 - 5 results of 5 for search 'Cho Wing Lo', query time: 0.03s
Refine Results
-
1
-
2
The efficacy and safety of Yupingfeng Powder with variation in the treatment of allergic rhinitis: Study protocol for a randomized, double-blind, placebo-controlled trial by Pui Kuan Cheong, Pui Kuan Cheong, Tin Muk Ho, Tin Muk Ho, Kam Leung Chan, Kam Leung Chan, Cho Wing Lo, Cho Wing Lo, Sin Bond Leung, Sin Bond Leung, Sin Bond Leung, Kam Lun Hon, Ka Chun Leung, Tony Hon Chung Siu, Tian-He Song, Tian-He Song, Hongwei Zhang, Hongwei Zhang, Jessica Yuet Ling Ching, Jessica Yuet Ling Ching, Jessica Yuet Ling Ching, Tak Yee Chow, Chi Him Sum, Chi Him Sum, Chon Pin Chia, Zhi-Xiu Lin, Zhi-Xiu Lin
Published 2022-12-01
Article -
3
Efficacy and safety of modified Xiao-Feng Powder in the treatment of chronic urticaria: protocol of a randomized double-blind placebo-controlled study by Hing Yu Hung, Tianhe Song, Steven King Fan Loo, Kam Leung Chan, Jessica Yuet Ling Ching, Chi Him Sum, Louis Cho Wing Lo, Sarah Chon Pin Chia, Ray Tin Muk Ho, Pui Kuan Cheong, Tony Hon Chung Siu, Ka Chun Leung, Zhi-Xiu Lin
Published 2022-07-01
Article -
4
Assessing the efficacy and safety of Yinqiao powder-maxing Ganshi decoction in the treatment of the major symptoms of mild and moderate COVID-19 by telemedicine–study protocol for... by Chi Him Sum, Tong Wendy Li, Hongwei Zhang, Hongwei Zhang, Hing Yu Hung, Ben Yuk Fai Fong, Ben Yuk Fai Fong, Wai Ling Lin, Tak Yee Chow, Ka Chun Leung, Cho Wing Lo, Chon Pin Chia, Kam Leung Chan, Kam Leung Chan, Zhi-xiu Lin, Zhi-xiu Lin
Published 2024-01-01
Article -
5
Chinese medicine for residual symptoms of COVID-19 recovered patients (long COVID)—A double-blind, randomized, and placebo-controlled clinical trial protocol by Chi Him Sum, Jessica Yuet Ling Ching, Tianhe Song, Pui Kuan Cheong, Pui Kuan Cheong, Cho Wing Lo, Mei Kwan Lai, Chon Pin Chia, Kam Leung Chan, Kam Leung Chan, Wing Yan Mak, Wing Yan Mak, Ka Chun Leung, Sin Bond Leung, Hongwei Zhang, Hongwei Zhang, Zhixiu Lin, Zhixiu Lin
Published 2023-01-01
Article